Dianthus Therapeutics, Inc. /DE/ SEC filings DNTH
Dianthus Therapeutics, Inc. /DE/ has 658 filings in SEC EDGAR's recent list, going back to Nov 23, 2016. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Other events
|
Jun 12, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Other events
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 12, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Other events
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Oct 16, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 11, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 8, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 22, 2025 | May 22, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Other events
|
Dec 12, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 28, 2024 | May 23, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 22, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Other events
|
Dec 21, 2023 | Dec 21, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Auditor change
|
Oct 25, 2023 | Oct 19, 2023 |
| 8-K/A |
Amended current report
Results of operations, Officer or director change, Other events
|
Sep 21, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Sep 12, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Sep 8, 2023 | Sep 8, 2023 |
| 8-K |
Current report
Officer or director change
|
May 19, 2023 | May 15, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Regulation FD disclosure
|
May 3, 2023 | May 2, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Apr 6, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Mar 31, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change
|
Feb 7, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Feb 2, 2023 | Jan 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 25, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 20, 2022 | Dec 20, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Dec 13, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Aug 17, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Material agreement, Results of operations
|
Aug 4, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2022 | Jun 28, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Officer or director change
|
May 2, 2022 | May 2, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 14, 2022 | Apr 14, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2022 | Mar 8, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 27, 2021 | Jul 21, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Officer or director change
|
May 27, 2021 | May 27, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
May 12, 2021 | May 12, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2021 | Mar 3, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2020 | Dec 22, 2020 |
| 8-K |
Current report
Officer or director change
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2020 | Oct 1, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2020 | Aug 31, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 30, 2020 | Jun 24, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 30, 2020 | Jun 24, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2020 | Jun 5, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 17, 2020 | Apr 14, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 16, 2020 | Apr 16, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2020 | Mar 3, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2019 | Nov 13, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2019 | Aug 8, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 24, 2019 | Jun 20, 2019 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2019 | Jun 7, 2019 |
| 8-K |
Current report
Results of operations
|
May 9, 2019 | May 9, 2019 |
| 8-K |
Current report
Other events
|
May 6, 2019 | May 1, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2019 | Mar 19, 2019 |
| 8-K |
Current report
Other events
|
Jan 24, 2019 | Jan 17, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2019 | Jan 7, 2019 |
| 8-K |
Current report
Officer or director change
|
Nov 19, 2018 | Nov 19, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2018 | Nov 8, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2018 | Aug 9, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jun 25, 2018 | Jun 20, 2018 |
Showing 89 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DNTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1690585
- Former names
- Magenta Therapeutics, Inc. (until Sep 8, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.